Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and...

Area of Science:

• Pediatrics
• Endocrinology
• Genetics

Background:

• Congenital hypothyroidism (CH) is a preventable cause of intellectual disability and growth failure.
• Newborn screening, primarily via thyroid-stimulating hormone (TSH) measurement, has transformed CH outcomes.
• Long-term neurodevelopmental outcomes in severe CH, even with early treatment, require further investigation due to historical data limitations and assessment challenges.

Purpose of the Study:

• To review current management strategies for congenital hypothyroidism.
• To highlight the need for updated consensus guidelines and prospective outcome assessments.
• To provide evidence-based recommendations for optimizing CH diagnosis and treatment.

Main Methods:

• Review of existing literature and clinical guidelines for congenital hypothyroidism management.
• Analysis of screening protocols, diagnostic algorithms, and treatment parameters.
• Discussion of neurodevelopmental assessment challenges in preschool children.

Main Results:

• Key recommendations include day 3 screening, a TSH referral cut-off of 8-10 mU/L, and a diagnostic algorithm involving free thyroxine (T4), TSH, thyroglobulin, and imaging.
• Initial T4 dosing strategies are outlined based on infant weight.
• Target maintenance levels for free T4 (15-26 pmol/L) and TSH (0.5-5 mU/L) are proposed to prevent under- or overtreatment.

Conclusions:

• Systematic, prospective assessment of children managed under new guidelines is essential for generating reliable outcome data.
• Optimized postnatal management, guided by updated consensus, is critical for mitigating potential cognitive and developmental deficits associated with CH.
• Continued research and standardized follow-up are necessary to fully understand and improve long-term outcomes for individuals with congenital hypothyroidism.